Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus

NCT03789526 — Not applicable, Completed, 52 participants, Al-Azhar University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03789526
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment52 (Actual)
SponsorAl-Azhar University (Other)
ConditionsUltrasound Guided Injection
Interventionsultrasound guidance (Procedure)
Datesstart 2018-12-11, primary completion 2019-01-31, completion 2019-02-01, first posted 2018-12-28, last updated 2019-06-11
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Ultrasound Guided Injection All trials of ultrasound guidance

-Summary

Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the management of tenosynovitis in DM patients.

Expand all sections  ·  Collapse all

+Detailed description

The current study will based on follow up study, conducted among patients presenting at outpatient rheumatology clinics of Al-Azhar University Hospitals, Egypt. with Diabetes mellitus duration at least 3 years and tenosynovitis of hand tendons with Richie tenderness grade 3.

All patients will randomized in two groups: Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance. Group two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.

The affected tendons will scanned and scored for inflammation using ultrasound in all patients before the triamcinolone injection and then to be reassessed one month after the injection to determine the change in the tendons in both groups.

+Arms and interventions

ArmTypeInterventionsDescription
Group 1ExperimentalProcedure: ultrasound guidance* Group one: 26 patients DM patients with tenosynovitis were injected by triamcinolone under ultrasound guidance.
Group 2No interventionGroup two: 26 patients DM patients with tenosynovitis were injected by triamcinolone under clinical guidance.
  • ultrasound guidance (Procedure): ultrasound guidance of tendon injection

+Outcome measures

Primary outcomes

  • change in Tenosynovitis pain [one month]: changes in VAS scale for pain,
  • change in Tenosynovitis tenderness [one month]: changes in Richie index for tenderness.
  • changes in ultrasound images of the Tenoasynovitis. [one month]: changes in Gery scale images, and power Doppler images of the tendons

+Eligibility

Sex: All

Inclusion Criteria:

* • Diabetes mellitus.

  * Disease duration 3 years or more.
  * Tenosynovitis of hand tendons with Richie tenderness grade 3.

Exclusion Criteria:

* • Patients with recent hand trauma.

  * Patients with inflammatory hand arthritis.
  * Previous tendon surgery.
  * Previous tendon injection.
  * Patients with contraindication for injection as related infection, uncontrolled DM or bleeding tendency.

+Locations (1)

FacilityCityCountryStatus
Al-Azhar university hospitalsCairoEgypt